BioPharma Credit (LON:BPCR) Stock Price Up 0.5% - Still a Buy?

Key Points

• BioPharma Credit shares increased by 0.5% to GBX 0.87 ($0.01), with approximately 223,748 shares traded, marking a significant 74% decrease in volume from the average.
• The company, founded in 2016, focuses on investing in interest-bearing debt assets backed by royalties or cash flows from approved life sciences products.
• BioPharma Credit has a market capitalization of £1.04 billion, a PE ratio of 9.91, and a beta of 0.22, indicating lower volatility relative to the market.

BioPharma Credit (LON:BPCR - Get Free Report) shares were up 0.5% on Tuesday . The stock traded as high as GBX 0.87 ($0.01) and last traded at GBX 0.87 ($0.01). Approximately 223,748 shares changed hands during mid-day trading, a decline of 74% from the average daily volume of 851,581 shares. The stock had previously closed at GBX 0.87 ($0.01).

BioPharma Credit Price Performance

The business's fifty day moving average is GBX 0.88 and its 200 day moving average is GBX 0.87. The firm has a market capitalization of £1.02 billion, a price-to-earnings ratio of 9.80 and a beta of 0.22.

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.